Infection Surveillance Solutions Market : Emerging Market Trends, Top Growing Segments and Future Trends
The rising healthcare expenditure, an increasing number of surgeries,
the growing geriatric population, and the increasing incidence of
chronic diseases are the other factors driving the growth of this
market. Currently, with the surge in COVID-19 cases, there is an
increased focus on personal hygiene, coupled with the need to track and
monitor the spread of COVID-19 infection. This is further expected to
drive the Infection Surveillance Solutions Market
growth during the forecast period. The growth of this market is
influenced primarily due to the increasing incidence of
hospital-acquired infections (HAIs) and new Medicare policies, including
non-payment for hospital-acquired conditions.
According
to the new market research report global Infection Surveillance
Solutions Market size is projected to reach USD 1,033 million by 2026
from USD 508 million in 2021, at a CAGR of 15.2%.
The
overall growth of various sectors has been heavily impacted by COVID-19,
specifically in countries with a high incidence rate of COVID-19, such
as India, China, Brazil, the US, and several European countries
(including Russia, Italy, and Spain). While industries such as oil and
petroleum, aeronautics, and mining are experiencing a steep fall in
revenues, the healthcare, biotechnology, and pharmaceutical industries
are optimizing this situation to serve a maximum number of patients and
healthcare professionals.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21857517
Based on product and services,
the Infection surveillance software market is segmented into software
and services. The infection surveillance software segment accounted for
the largest share of the market. The large share of this segment can be
attributed to the increasing need for preventing HAIs and the growing
number of surgical procedures.
Based on type,
the infection surveillance software market is segmented into on-premise
and web-based software. The on-premise software segment accounted for
the largest share of the market. The large share of this segment is
mainly attributed to the need for maintaining access to healthcare IT
solutions and reduce the risk of data breaches external attacks.
Becton,
Dickinson and Company (US), Cerner Corporation (US), Wolters Kluwer
N.V. (Netherlands), Premier International Inc. (US), Baxter Corporation
(US) are the leading players in the infection surveillance solution
market
The global infection surveillance software market is fragmented and highly competitive.
Some of the major players governing the overall infection surveillance
solutions market include Becton, Dickinson and Company (US), Premier
Inc. (US), Wolters Kluwer N.V. (Netherlands), Cerner Corporation (US),
Baxter International Inc. (US), GOJO Industries, Inc. (US), Sunquest
(US), Deb Group Ltd. (UK), BioVigil Healthcare Systems (US), RLDatix
(UK), IBM Corporation (US), Vecna Technologies, Inc. (US), VigiLanz
Corporation (US), Ecolab Inc. (US), Harris Healthcare (US), PeraHealth
Inc. (US), Medexter Healthcare (Austria), Centrak Inc. (US), BioMerieux
SA (France), CKM Healthcare (Canada). However, in the last few years, a
number of smaller players have emerged from niche markets and are
competing with global players based on price and technological
innovation. Due to the intense competition in the market, major market
players are increasingly focusing on expanding their geographic presence
into high-growth emerging markets and strengthening their
competitiveness in the market by acquiring smaller players with desired
technological capabilities or geographic presence.
Becton, Dickinson and Company is a leading company in the infection surveillance solutions market
and is a leading provider of infection surveillance products and
services. The company offers a broad range of infection surveillance
solutions and has facilities in the U.S., Brazil, Canada, China, France,
Germany, Hungary, India, Ireland, Japan, Mexico, the Netherlands,
Pakistan, Singapore, Spain, and the U.K. The company operates in three
business segments worldwide—BD Medical, BD Life Sciences and BD
Interventional. The company offers infection surveillance solutions
under the BD Medical segment. MedMined Surveillance Advisor, BD Protect
Infection Prevention, and BD AICE are the major infection surveillance
software developed and marketed by the company. The company
significantly invests in RD activities to add technologically innovative
solutions to its portfolio, which helps it to further strengthen its
presence in the infection surveillance solutions market.
This
study involved the extensive use of both primary and secondary sources.
The research process involved the study of various factors affecting the
industry to identify the segmentation types, industry trends, key
players, competitive landscape, key market dynamics, and key player
strategies.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=21857517
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment